Kan. Admin. Regs. § 68-7-22 - Collaborative practice
(a) Each
of the following terms, as used in this regulation, shall have the meaning
specified in this subsection:
(1)
"Collaborative drug therapy management" and "CDTM" mean a practice of pharmacy
in which a pharmacist performs certain pharmaceutical-related patient care
functions for a specific patient, and the functions have been delegated to the
pharmacist by a physician through a collaborative practice agreement.
(2) "Collaborative practice agreement" and
"CPA" mean a signed agreement or protocol voluntarily entered into between one
or more pharmacists and one or more physicians that provides for collaborative
drug therapy management.
(3)
"Pharmacist" means a person licensed, without limitation or restriction, to
practice pharmacy in Kansas.
(4)
"Physician" means a person who is licensed to practice medicine and surgery in
Kansas and who is a signing party to the pharmacist's CPA or
update.
(b) Any
pharmacist may practice collaborative drug therapy management only pursuant to
a collaborative practice agreement or update established and maintained in
accordance with this regulation. Although a physician shall remain ultimately
responsible for the care of the patient, each pharmacist who engages in CDTM
shall be responsible for all aspects of the CDTM performed by the pharmacist.
A pharmacist shall not become a party to a CPA or update that authorizes the pharmacist to engage in any CDTM function that is not appropriate to the training and experience of the pharmacist or physician, or both. A pharmacist shall not provide CDTM to a patient if the pharmacist knows that the patient is not being treated by a physician who has signed the pharmacist's current CPA.
(c)
(1)
Each CPA and update shall be dated and signed by each physician and each
pharmacist. Each CPA and update shall include the following:
(A) A statement of the general methods,
procedures, and decision criteria that the pharmacist is to follow in
performing CDTM;
(B) a statement of
the procedures that the pharmacist is to follow to document the CDTM decisions
made by the pharmacist;
(C) a
statement of the procedures that the pharmacist is to follow to communicate to
the physician either of the following:
(i)
Each change in a patient's condition identified by the pharmacist; or
(ii) each CDTM decision made by the
pharmacist;
(D) a
statement identifying the situations in which the pharmacist is required to
initiate contact with the physician; and
(E) a statement of the procedures to be
followed by the pharmacist if an urgent situation involving a patient's health
occurs, including identification of an alternative health care provider that
the pharmacist should contact if the pharmacist cannot reach a
physician.
(2) A CPA
shall not authorize a pharmacist to administer influenza vaccine except
pursuant to
K.S.A. 65-1635a, and amendments
thereto.
(d) Each CPA and
update shall be reviewed and updated at least every two years. A signing
pharmacist shall deliver a digital or paper copy of each CPA and update to the
board within five business days after the CPA or update has been signed by all
parties.
(e) Within 48 hours of
making any drug or drug therapy change to a patient's treatment, the pharmacist
shall initiate contact with a physician, identifying the change.
(f) This regulation shall not be interpreted
to impede, restrict, inhibit, or impair either of the following:
(1) Current hospital or medical care facility
procedures established by the hospital or medical care facility pharmacy and
either the therapeutics committee or the medical staff executive committee;
or
(2) the provision of medication
therapy management as defined by the centers for medicare and medicaid services
under the medicare part D prescription drug benefit.
(g) As part of each pharmacist's application
to renew that individual's license, the pharmacist shall advise the board if
the pharmacist has entered into a CPA.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.